Halozyme Therapeutics, Inc. (HALO) SEC Filings — 2024
13 SEC filings for Halozyme Therapeutics, Inc. (HALO) in 2024.
Filings
- Halozyme Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Halozyme Therapeutics Files Q3 2024 Report — 10-Q · Oct 31, 2024
- Halozyme Therapeutics, Inc. SC 13G Filing — SC 13G · Oct 17, 2024
- Halozyme Therapeutics Q2 Revenue Declines — 10-Q · Aug 6, 2024
- Halozyme Therapeutics Reports Q1 2024 Results — 10-Q · May 7, 2024
- Halozyme Therapeutics Files 8-K on Shareholder Vote and Exhibits — 8-K · Apr 26, 2024
- Halozyme Therapeutics, Inc. Announces 2024 Annual Meeting of Stockholders — DEF 14A · Mar 15, 2024
- Halozyme Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 20, 2024
- Halozyme Therapeutics, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Artisan Partners Amends Halozyme Therapeutics Stake (SC 13G/A) — SC 13G/A · Feb 12, 2024
- Invesco Amends Halozyme Therapeutics Stake as of Dec 29, 2023 — SC 13G/A · Feb 1, 2024
- BlackRock Amends Halozyme Therapeutics Stake, Filing SC 13G/A — SC 13G/A · Jan 23, 2024
- HALOZYME Files 8-K on Operations & Financial Condition — 8-K · Jan 17, 2024